<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Peter-John Wormald</title>
<copyright>Copyright (c) 2011  All rights reserved.</copyright>
<link>http://works.bepress.com/peterj_wormald</link>
<description>Recent documents in Peter-John Wormald</description>
<language>en-us</language>
<lastBuildDate>Fri, 09 Sep 2011 01:52:36 PDT</lastBuildDate>
<ttl>3600</ttl>


	
		
	

	
		
	

	
		
	







<item>
<title>Staphylococcus aureus biofilms: nemesis of endoscopic sinus surgery</title>
<link>http://works.bepress.com/peterj_wormald/36</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/36</guid>
<pubDate>Wed, 07 Sep 2011 23:45:34 PDT</pubDate>
<description>
	<![CDATA[
	<p>Objectives/Hypothesis: Chronic rhinosinusitis (CRS) patients with biofilms have persistent postoperative symptoms, ongoing mucosal inflammation, and recurrent infections. Recent evidence suggests that biofilms of differing species confer varying disease profiles in CRS patients. We aimed to prospectively investigate the effects of Staphylococcus aureus, Pseudomonas aeruginosa, Haemophilus influenzae, and fungal biofilms on outcomes following endoscopic sinus surgery (ESS).</p>
<p>Study Design: Prospective blinded study.</p>
<p>Methods: In this prospective blinded study, 39 patients undergoing ESS for CRS assessed their symptoms preoperatively using internationally accepted standardized symptom scoring systems and quality-of-life measures (10-point visual analog scale, Sino-Nasal Outcome Test-20, global severity of CRS). Their sinonasal mucosa was graded (Lund–Kennedy scale) and extent of radiologic disease on computed tomography scans scored (Lund-McKay scale).  Random sinonasal tissue samples were assessed for different bacterial species forming biofilms by using fluorescent in-situ hybridization and confocal laser microscopy.</p>
<p>For 12 months after surgery, CRS symptoms, quality of life, and objective evidence of persisting disease were assessed by using the preoperative tools.</p>
<p>Results: Different bacterial species combinations were found in 30 of 39 patients; 60% of these 30 biofilms were polymicrobial biofilms and 70% had S aureus biofilms.  Preoperative nasendoscopy and radiologic disease severity were significantly worse in patients with multiple biofilms (P ¼ .02 and P ¼ .01, respectively), and they had worse postsurgery mucosal outcomes on endoscopy (P ¼ .01) requiring significantly more postoperative visits (P ¼ .04). Those with S aureus biofilms progressed poorly with their symptom scores and quality-of-life outcomes, with significant differences in nasendoscopy scores (P ¼ .007).</p>
<p>Conclusions: S. aureus biofilms play a dominant role in  negatively affecting outcomes of ESS with persisting postoperative symptoms, ongoing mucosal inflammation, and infections.</p>
<p>Level of Evidence: 1c.</p>

	]]>
</description>

<author>D Singhal et al.</author>


</item>






<item>
<title>A vascular catastrophe during endonasal surgery: an endoscopic sheep model.</title>
<link>http://works.bepress.com/peterj_wormald/35</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/35</guid>
<pubDate>Wed, 07 Sep 2011 20:17:23 PDT</pubDate>
<description>
	<![CDATA[
	<p>Internal carotid artery (ICA) injury is a dramatic complication of endonasal skull base approaches with massive bleeding. This study aims to design an animal modle of ICA injury during endonasal base surgery. Eight sheep underwent ICA isolation followed by arterial pressure monitoring and placement of a rapid infuser. The Sinus Model Otorhino Neuro Trainer (Pro Delphus, Pernambuco, Brazil) nasal model was then modified. A novel posterior sphenoid wall was created, allowing the artery to be placed within and fixed to the model in a watertight fashion. A diamond-tipped bur allowed surgical exposure of the carotid artery. A standardized injury was created endoscopically. The 'two-surgeon technique' allowed local packing measures to be performed. Outcome measures were mean arterial presure (MAP) following injury, resuscitation fluid volume, survival time, and total blood loss. Mean pre-injury weight was 51.8 ± 4.59 kg.  All baseline hematologic parameters fell within normal limits. The mean preinjury and postinjury MAP was 65.7 ± 9.3 mm Hg versus 39.1 ± 6.9 mm Hg, respectively. The mean survival time was 50.25 ± 17.89 minutes, with mean resuscitation fluid volume of 10.89 ± 2.40 L and mean blood loss of 4943 ± 1089 mL. This model replicates the endoscopic surgical field of an ICA injury, with the potential to train endoscopic skull base teams in the skills required to manage an ICA injury.</p>

	]]>
</description>

<author>R Valentine et al.</author>


</item>






<item>
<title>Patient-reported olfactory function following endoscopic sinus surgery with modified endoscopic Lothrop procedure / Draf 3.</title>
<link>http://works.bepress.com/peterj_wormald/34</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/34</guid>
<pubDate>Wed, 07 Sep 2011 19:30:39 PDT</pubDate>
<description>
	<![CDATA[
	<p>Objectives/Hypothesis: The Modified Endoscopic Lothrop procedure (MELP) or Draf 3 is a complex procedure, performed for chronic frontal sinusitis that is refractory to standard functional endoscopic sinus surgery. The procedure involves drilling of the frontal T (formed by the septum and middle turbinate’s attachment to the skull base) onto the olfactory fossa often with exposure of the first olfactory neuron and may affect olfactory function. This study was performed to assess patients’ subjective sense of smell following this procedure.</p>
<p>Study Design: Prospective study of retrospective data.  Methods: Sixty-eight patients, who underwent modified endoscopic Lothrop by the senior author (PJW) between 2003 and 2008, completed a post-operative questionnaire asking about their perception of olfactory function. All  patients had their pre-operative subjective sense of smell documented prior to undergoing surgery. Patient records were reviewed for pertinent medical information such as the presence of asthma, aspirin sensitivity and nasal polyps.</p>
<p>Results: This study found that the majority of patients reported improvement in their sense of smell post-operatively, while only a small number reported a negative impact on their smell. Thirty-nine patients reported an improvement in their post-operative smell grade. Twenty patients reported no change in their smell grade, while the remaining 9 patients stated that their sense of smell worsened after surgery. No statistically significant  correlation was found between patient outcome and the  presence of asthma, nasal polyps, or Samter’s triad.</p>
<p>Conclusions: The Modified endoscopic Lothrop procedure/ Draf 3 had a positive effect on subjective sense of smell post-operatively in this cohort of patients.</p>

	]]>
</description>

<author>J Yip et al.</author>


</item>






<item>
<title>Are routine dissolvable nasal dressings necessary following endoscopic sinus surgery?</title>
<link>http://works.bepress.com/peterj_wormald/33</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/33</guid>
<pubDate>Wed, 12 Jan 2011 17:48:54 PST</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND</p>
<p>Nasal dressings have frequently been advocated to improve wound healing and prevent ongoing bleeding after endoscopic sinus surgery (ESS). Initial experience focused on removable nasal packing materials; however, their adverse effect profile, such as pain/discomfort and mucosal trauma, has driven the development of absorbable biomaterials. Despite these developments, there is still little agreement on the optimal choice of nasal dressing or whether nasal dressings are required at all.</p>

	]]>
</description>

<author>R Valentine et al.</author>


</item>






<item>
<title>The clinical significance of nasal irrigation bottle contamination.</title>
<link>http://works.bepress.com/peterj_wormald/32</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/32</guid>
<pubDate>Wed, 12 Jan 2011 17:39:29 PST</pubDate>
<description>
	<![CDATA[
	<p>Objectives/Hypothesis: This study aimed to assess the clinical relevance of contamination of nasal irrigation bottles in patients with recalcitrant chronic rhinosinusitis (CRS). Secondary investigations to identify the presence of bacterial biofilms on the inner surface of the bottles and to assess different sterilization methods were also undertaken.</p>
<p>Study Design: Prospective, observational.</p>
<p>Methods: Eleven patients with recalcitrant CRS who were already using nasal irrigation as part of their treatment regimen were examined every 2 weeks for a period of 6 weeks. At each visit, a culture sample was taken from their irrigation bottle and middle meatus, and they were given a new irrigation bottle. Irrigation bottles from six patients were analyzed with scanning electron microscopy (SEM) to detect biofilm formation. Finally, new bottles were innoculated with different strains of Staphylococcus aureus and then cleaned with different methods. The bottles were cultured immediately after cleaning and 48 hours later.</p>
<p>Results: Overall, 42 of 43 (97%) bottles collected demonstrated bacterial growth. Concurrent sinonasal and bottle infection with S. aureus was seen in 51% of patients during the study. Bacterial biofilms were demonstrated on the inner surface of four of the six irrigation bottles tested. Treatment with Milton’s solution (1% NaOCl plus 19% NaCl) and microwaving were found to be effective methods for sterilizing the bottles both initially after the cleaning and 48 hours later.</p>
<p>Conclusions: Patients who irrigate their nose and sinuses commonly contaminate their irrigation bottle, most often with S. aureus, which can be in the biofilm form. Simple cleaning methods could reduce contamination of the bottles.</p>

	]]>
</description>

<author>M Keen et al.</author>


</item>






<item>
<title>Effect of head position and surgical dissection on sinus irrigant penetration in cadavers.</title>
<link>http://works.bepress.com/peterj_wormald/31</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/31</guid>
<pubDate>Wed, 12 Jan 2011 17:29:25 PST</pubDate>
<description>
	<![CDATA[
	<p>Background: Effective treatment for recalcitrant rhinosinusitis requires unobstructed surgical marsupialization of sinus cavities and use of delivery systems that will topically penetrate the sinuses.</p>
<p>Aims: To determine the extent of sinus penetration achieved with nasal irrigation by varying the ostial size and head position.</p>
<p>Methods: Ten thawed fresh-frozen cadaver heads were dissected in a staged manner. After each stage of dissection, sinus squeeze-bottle irrigations were performed in three head positions, and endoscopes placed via external ports into the sinus cavities viewed the sinus ostia. An ordinal scale was developed to grade ostial penetration of irrigations. Three reviewers independently graded the outcomes.</p>
<p>Results: Irrigant entry into sinuses increased with ostial size (P < .001) and the greatest differential of improvement in sinus penetration is obtained at an ostial size of 4.7 mm. Stages 2 and 3 (larger sinus ostia) of maxillary and sphenoid dissections have statistically greater irrigant  penetration relative to earlier stages. Frontal sinus irrigation is worse in vertex to ceiling head position. There does not appear to be any significant advantage to head position with maxillary and sphenoid sinuses.</p>
<p>Conclusions: This study shows that the larger the sinus ostium, the better the penetration of irrigant irrigant into the sinus, with an ostium of at least 4.7mm allowing maximal penetration in the maxillary and sphenoid sinuses. The same benefit was not noted in the frontal sinus. Head position was only relevant to the frontal sinus where less penetration was seen with the head neutral (vertex to ceiling) position when compared to forward angled positions.</p>

	]]>
</description>

<author>D Singhal et al.</author>


</item>






<item>
<title>Aberrant mucin glycoprotein patterns of chronic rhinosinusitis patients with bacterial biofilms</title>
<link>http://works.bepress.com/peterj_wormald/30</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/30</guid>
<pubDate>Thu, 04 Nov 2010 19:48:16 PDT</pubDate>
<description>
	<![CDATA[
	<p>Background: Increasingly bacterial biofilms have been implicated in chronic rhinosinusitis (CRS), and conventional treatment methods have failed to completely eradicate biofilms. (1) Terminal sialic acids present on sinus mucosal glycoproteins are targets for bacterial adherence and biofilm formation. (2) A subpopulation of CRS patients is more susceptible to biofilm formation due to aberrant terminal sialic residue distribution patterns of glycoproteins on their mucosa. (3) The higher levels of sialyl transferase (ST)6Gal1 gene expression contribute to the overall aberrant glycosylation patterns on the host mucosa that predispose this patient cohort to developing biofilms. (4) Mucin glycoprotein MUC7 that has known bactericidal activity displays an overall reduced terminal sugar profile in biofilm positive CRS patients.</p>
<p>Methods: Confocal scanning laser microscopy, glycoarray analysis, real-time polymerase chain reaction of ST6Gal1, neuraminidase assays and multivariate analysis were used to compare production of sialic acid– degrading enzymes in sinus biopsies from biofilm positive and negative CRS patients with mucosa from healthy controls.</p>
<p>Results: Biofilm-positive CRS patients expressed aberrant glycoprotein patterns with terminal sialics of between 70 and 90 kD (stress value  0.1414). The ST6Gal1 gene was upregulated, and bacteria isolated from these patients exhibit significantly higher neuraminidase activity (p  0.0343). We detected a significant lack in the overall expression of terminal sugar residues of MUC7 (stress value  0.088).</p>
<p>Conclusions: We observed a strong positive correlation between the aberrant terminal sugar patterns in this sub group of CRS patients with biofilms. The innate immunity function of their MUC7 glycoprotein against bacterial invasion may be compromised in CRS patients.</p>

	]]>
</description>

<author>L Tan et al.</author>


</item>






<item>
<title>Planning for the canine fossa trephination approach.</title>
<link>http://works.bepress.com/peterj_wormald/29</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/29</guid>
<pubDate>Thu, 07 Oct 2010 16:37:09 PDT</pubDate>
<description>
	<![CDATA[
	<p>Complete removal of polyps and thick mucus from the severely diseased maxillary sinus is key in allowing the resolution of symptoms. The canine fossa trephination (CFT) procedure is a highly effective means of clearing diseased material from all areas of the maxillary sinus and is especially useful in patients with Sampter's triad and fungal sinusitis. However, many surgeons have failed to adopt this technique for fear of its potential complications. Numerous technical refinements have been developed in recent years, significantly reducing the rate of adverse outcomes following CFT. This article describes the steps involved in performing the CFT, with an emphasis on the avoidance of complications.</p>

	]]>
</description>

<author>M Tewfik et al.</author>


</item>






<item>
<title>Innate immunity</title>
<link>http://works.bepress.com/peterj_wormald/28</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/28</guid>
<pubDate>Wed, 25 Aug 2010 18:30:39 PDT</pubDate>
<description>
	<![CDATA[
	<p>The sinonasal tract is continuously exposed to environmental particulates and pathogens which are normally cleared by efficient host defenses. The innate immune system forms the first line of defense against these aerosolized pathogens and, although typically constitutive, has also been found to be inducible. One sigificant component of the innate immune system is the cellular structure of the sinonasal mucosal lining itself. This lining consists of the ciliated respiratory epithelium, goblet cells, subepithelial cells (dendritic cells, macrophages, leucocytes, plasma cells) and glands, which all contribute to pathogen clearance in several ways.</p>

	]]>
</description>

<author>E Ooi et al.</author>


</item>






<item>
<title>Ten pearls for safe endoscopic sinus surgery</title>
<link>http://works.bepress.com/peterj_wormald/27</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/27</guid>
<pubDate>Thu, 29 Jul 2010 18:56:57 PDT</pubDate>
<description>
	<![CDATA[
	<p>Endoscopic sinus surgery (ESS) is effective in improving the symptoms of chronic rhinosinusitis and thus in ameliorating the quality of life of patients suffering from this common disease. However, one important drawback to this type of surgery remains the potential for serious complications. This is inevitably because of the proximity of critical anatomic structures such as the orbit, the internal carotid arteries, the skull base, dura, and brain.</p>

	]]>
</description>

<author>M Tewfik et al.</author>


</item>






<item>
<title>Surgical outcomes of endoscopic management of adenocarcinoma of the sinonasal cavity</title>
<link>http://works.bepress.com/peterj_wormald/26</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/26</guid>
<pubDate>Tue, 23 Mar 2010 22:51:42 PDT</pubDate>
<description>
	<![CDATA[
	<p>Objective: To report the surgical outcomes of endoscopic resection of adenocarcinomas of the sino-nasal cavity.</p>
<p>Methods: Retrospective chart reviews of patients presenting with adenocarcinoma of the anterior skull base between 1998-2008. All patients who underwent wholly endoscopic resection were included in the study.</p>
<p>Results: twelve patients presented with adenocarcinoma involving the sino-nasal cavity. At diagnosis 6 patients were staged as a T2, 5 as a T3 and one as a T4. All of the patients had successful removal of the tumour entirely endoscopically. Three patients recurred: 2 locally and 1 with distant metastases. Overall, 11 patients are alive and free of disease and 1 patient dead of disease. We found an overall disease free survival rate and overall survival rate of 91.6%. the follow-up period ranged from 10 to 96 months with a median of 30 months.</p>
<p>Conclusion: Endoscopic management of adenocarcinoma of the sino-nasal cavity can be a viable treatment option to craniofacial resection. With the advancement in endoscopic equipment and surgeon skill, larger tumours may be managed wholly endoscopically.</p>

	]]>
</description>

<author>C Jardeleza et al.</author>


</item>






<item>
<title>Advances in absorbable biomaterials and nasal packing</title>
<link>http://works.bepress.com/peterj_wormald/25</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/25</guid>
<pubDate>Tue, 19 Jan 2010 16:31:10 PST</pubDate>
<description>
	<![CDATA[
	<p>Background: Nasal Packing in  Endoscopic Sinus Surgery. Endoscopic sinus surgery (ESS) is a continuously developing field that has had many exciting developements in the past 3 decades. Advances in the understanding of functional sinus surgery and mucosal-sparing techniques has driven an interest in the management of the post-ESS nasal and sinus cavity to achieve more rapid postoperative reepithelialization and reciliation. Many surgeons believe that the postoperative treatment regimen is as important as the surgery.</p>

	]]>
</description>

<author>Rowan Valentine et al.</author>


</item>






<item>
<title>Nasal polyp cell populations and fungal-specific peripheral blood lymphocyte proliferation in allergic fungal sinusitis</title>
<link>http://works.bepress.com/peterj_wormald/24</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/24</guid>
<pubDate>Tue, 01 Dec 2009 17:47:02 PST</pubDate>
<description>
	<![CDATA[
	<p>Background: Allergic fungal sinusitis (AFS) is considered a different disease from other polypoid chronic rhinosinusitis diseases (CRS) with eosinophilic mucus (EM) termed eosinophilic mucus chronic rhinosinusitis (EMCRS). To substantiate this, studies on cellular responses to fungi and sinus mucosal inflammatory cell populations in AFS and other EMCRS diseases are required. This study was designed to examine polyp inflammatory cell populations and peripheral blood fungal-specific T cell responses in AFS, other EMCRS subgroups (defined later) and polypoid CRS without EM. Methods: A prospective study was performed. Clinical characteristics, including CRS symptoms, sinus computed tomography (CT) scans, allergy status, intraoperative endoscopy, presence of EM, and fungal culture results were used to define patient groups. Polyps and peripheral blood were examined for populations of eosinophils, lymphocytes (CD4+, CD8+ T cells, natural killer cells, and B cells) and neutrophils using immunohistochemistry, cytospin preparations and flow cytometry. Fungal-specific peripheral blood lymphocyte proliferation was examined in AFS patients, other EMCRS patients, CRS patients and controls. Results: There was no significant difference in the percentage of cell populations and fungal-specific lymphocyte proliferation between AFS and other EMCRS diseases. However, AFS and other  EMCRS polyps had a higher percentage of eosinophils and CD8+ T cells whereas CRS polyps had higher CD4+ T cells. Fungal-specific lymphocyte proliferation was significantly greater in AFS and other EMCRS patients regardless of fungal allergy, whereas in CRS and controls, higher proliferation was observed in fungal-allergic individuals. Conclusion: These findings question the basis for differentiating AFS from other EMCRS diseases based on fungal allergy and fungi in EM. Fungal-specific cellular response was present in AFS and other EMCRS diseases, different from that associated with fungal allergy, suggesting a nonallergic fungal immune response. Increased CD8+ T cells in EMCRS polyps signify a different type of inflammation to CRS that may be driven by CD8+ T cells.</p>

	]]>
</description>

<author>H Pant et al.</author>


</item>






<item>
<title>The role of itraconazole in recalcitrant fungal sinusitis</title>
<link>http://works.bepress.com/peterj_wormald/23</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/23</guid>
<pubDate>Thu, 19 Nov 2009 20:01:28 PST</pubDate>
<description>
	<![CDATA[
	<p>Background: Oral itraconazole is an antifungal that has been shown to be of benefit to patients with allergic bronchopulmonary aspergillus (ABPA). It is hypothesized that itraconazole may similarly benefit patients with allergic fungal sinusitis (AFS), a disease similar to ABPA. This study was designed to evaluate the therapeutic response of itraconazole in patients with refractory chronic fungal sinusitis who have failed maximal medical and surgical therapy.</p>
<p>Methods: A retrospective chart review was performed of 23 patients with AFS and nonallergic eosinophilic fungal sinusitis treated with oral itraconazole. Charts were reviewed for patient demographics, comorbidities, allergies, fungal cultures, type of surgery performed, and amount of oral steroids used before and after itraconazole. All patients were given a 6-month dose of itraconazole (100mg b.i.d.) when recurrence developed after surgery. Time to next recurrence, change in oral steroid use, and outcomes were noted. Liver function tests were taken at monthly intervals while on itraconazole.</p>
<p>Results: Twenty-three patients, 13 men and 10 women, were started on oral itraconazole for recurrent fungal sinusitis. Nineteen patients rsponded to the medication with a decrease in symptoms and fungal mucin/ polyps on endoscopy. Three patients had to stop because of elevated liver enzymes. In the remaining 16 patients a decrease in oral steroid use was noted. In addition, 11 of the 16 patients are disease free to date at a mean follow-up of 15.7 months. No permanent complications occurred from the use of the medication.</p>
<p>Conclusion: Oral itraconazole may be of benefit to those patients with recalcitrant fungal sinusitis who have failed maximal medical and surgical therapy. Itraconazole may prolong the time to next recurrence and may enable the patient to significantly decrease or stop oral steroids.</p>

	]]>
</description>

<author>K Seiberling et al.</author>


</item>






<item>
<title>Endoscopic management of frontal sinus osteomas revisited</title>
<link>http://works.bepress.com/peterj_wormald/22</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/22</guid>
<pubDate>Thu, 19 Nov 2009 19:43:04 PST</pubDate>
<description>
	<![CDATA[
	<p>Background: recent articles have published guidelines regarding the role of endoscopic surgery in the removal of frontal sinus osteomas. These guidelines recommend the endoscopic approach for small ostoemas but recommend an osteoplastic flap for larger tumors. This study presents a series of endoscopically resected tumors both large and small. Methods: retrospective chart reviews were performed. Charts were reviewed of all patients who underwent surgical resection of a frontal sinus osteoma from 1998 to 2008. Sinus CT scans were reviewed and each tumor was staged according to Kennedy's grading system proposed in 2005. Results: Twenty-three patients, 8 with a grade IV tumor, 6 with a grade III tumor, and the remaining with a grade I or II tumor, underwent endoscopic resection of a frontal sinus osteoma. In 15 patients a modified Lothrop procedure was performed for tumor removal. In addition, a blepharoplasty incision was used in one patient for removal of a large orbital extension of the tumor and another underwent an enlarged frontal sinus trephine performed via a browline incision. In the remaining patients a frontal sinusotomy with minitrephination provided enough access for tumor removal. Over an average follow-up of 36 months no recurrences were noted. Symptoms improved in all but one patient. There were no postoperative complications. Conclusion: Endoscopic resection of both large and small frontal sinus osteomas is feasible. In this article we have shown successful removal of large osteomas that fill the entire frontal sinus with the modified Lothrop procedure.</p>

	]]>
</description>

<author>K Seiberling et al.</author>


</item>






<item>
<title>Immunomodulatory effect of cytosine-phosphate-guanosine (CpG)-oligonucleotides in nonasthmatic chronic rhinosinusitis: an explant model</title>
<link>http://works.bepress.com/peterj_wormald/21</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/21</guid>
<pubDate>Thu, 19 Nov 2009 18:22:10 PST</pubDate>
<description>
	<![CDATA[
	<p>Background: The use of cytosine-phosphate-guanosine-oligodeoxynucleotides (CpG-ODNs) or immunostimulatory sequences (ISSs) in the treatment of airway diseases is gaining interest. Binding of the CpG-ODN ligand to Toll-like receptor 9 (TLR9) triggers a shift from a Th2- to a Th1-type response in the target tissue. In this study, we explored the potential use of CpG-ODN to dampen the predominantly Th2-driven chronic inflammatory state in our cohort of patients. Methods: An in vitro explant model comprising of sinonasal tissue from patients with asthma (n=12) and without asthma (n=11) were stimulated with CpG-ODN or Staphylococcus aureus enterotoxin B (SEB) or CpG-ODN in combination with SEB for 48 hours. Ten of the 12 asthma patients had nasal polyps. RNA was extracted for multiplex real-time reverse transcription polymerase chain reaction analysis and the 2~delta delta Ct method was used to determine interleukin (IL)-5, p35 IL-12, interferon (IFN) gamma, and TLR9 expression levels. Results: CpG-ODN significantly reduced IL-5 mRNA expression in patients without asthma (p=0.0379) but not in the asthma-associated group. SEB alone caused an increase in IL-5 levels that could be dampened when CpG-ODN was added in combination with SEB. Significant differences in mean IL-5 expression levels between the asthmatic and non-asthmatic categories were detected (Welch t-test; **p=0.0041). Asthmatic and nonasthmatic patients present as two distinct catagories as reflected by significant differences in their IL-5 response to CpG-ODN (F=11.93; ***p=0.0008), SEB (F=41.34; *p=0.0476) and CpG-ODN with SEB (F=13.2; *p=0.0114). In contrast, no significant differences were observed in the expression levels of IL-12, IFN-gamma and TLR9. Conclusion: Localized application of CpG-ODN on its own or in combination with SEB may potentially reduce the expression of the proinflammatory cytokine IL-5 in non-asthmatic patients and may be further developed as an immunotherapeutic agent.</p>

	]]>
</description>

<author>L Tan et al.</author>


</item>






<item>
<title>Minitrephination of the frontal sinus: indications and uses in today&apos;s era of sinus surgery</title>
<link>http://works.bepress.com/peterj_wormald/20</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/20</guid>
<pubDate>Thu, 19 Nov 2009 17:47:05 PST</pubDate>
<description>
	<![CDATA[
	<p>Background: This study reviews the role of frontal sinus minitrephination in today's era of endoscopic sinus surgery. Retrospective chart review was performed of 163 patients undergoing a total of 149 bilateral and 39 unilateral frontal sinus minitrephinations. Methods: Charts were reviewed for patient demographics and outcomes. Details obtained from the chart included type of surgery performed, reason for minitrephination placement, pathology, Lund score, complications and endoscopic patency. Results: One hundred eighty-eight minitrephines were placed during 80 modified Lothrop and 108 frontal sinusotomies. Trephines were placed where there was dificulty finding the frontal recess, severe edema/ polyps, obstructing frontal cells (type3/ type 4 frontoethmoidal cells and intersinus septum cell), and to aid the dissection and postoperative irrigation during the modified Lothrop. Twelve complications occurred with infection at the trephine site being the most common. Follow-up ranged from 2 to 122 months (average, 25.5 months) with 92% showing endoscopic patency at least visit. Conclusion: Frontal sinus trephination is a safe useful procedure that can be extremely helpful in identifying the pathway to the frontal sinus. Fluorscein flushes through the trephine help guide the dissection in a modified Lothrop. Lastly, it may be used in the postoperative period to flush the sinus with saline and steroids to promote patency of the frontal sinus.</p>

	]]>
</description>

<author>K Seiberling et al.</author>


</item>






<item>
<title>Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis</title>
<link>http://works.bepress.com/peterj_wormald/19</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/19</guid>
<pubDate>Thu, 05 Nov 2009 17:00:30 PST</pubDate>
<description>
	<![CDATA[
	<p>Objectives/Hypothesis: To examine the efficacy and tolerability of topical mupirocin for the management of surgically recalcitrant chronic rhinosinusitis (CRS) associated with Staphylococcus aureus infection. Study Design: Prospective open-label pilot study. Methods: Patients with surgically recalcitrant CRS who had positive nasendoscopically guided cultures for Staphylococcus aureus were treated with twice daily nasal lavages containing 0.05% Mupirocin and lactated ringer salts. The duration of treatment was 8 weeks. Patients were assessed before and after treatment in terms of nasoendoscopic findings, microbiology results and Sinonasal Outcomes Test (SNOT-20) and visual analogue scale questionnaires. Results: Fifteen of 16 patients had improved nasoendoscopic findings after treatment. Twelve of 16 patients noted overall symptom improvement. Fifteen of 16 patients had negative swab results for Staphylococcus aureus after treatment. Only minimal adverse effects were experienced. Conclusions: Nasal Lavage with 0.05% Mupirocin may represent an effective and well tolerated alternative treatment for post-surgical recalcitrant CRS.</p>

	]]>
</description>

<author>B Uren et al.</author>


</item>






<item>
<title>Efficacy of different techniques of sinonasal irrigation after modified Lothrop procedure.</title>
<link>http://works.bepress.com/peterj_wormald/18</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/18</guid>
<pubDate>Thu, 05 Nov 2009 16:29:44 PST</pubDate>
<description>
	<![CDATA[
	<p>Background: Post-operative irrigation after endoscopic sinus surgery and endoscopic Lothrop procedure is used to remove nasal crusts and to improve wound healing. To evaluate the optimal application protocol for irrigation of the frontal sinus, a prospective cadaver study was performed. Methods: An endoscopic modified Lothrop procedure and complete sphenoethmoidectomy were performed in 19 heads. Each was irrigated with a 1.5% solution of water and different colours using nasal spray and a squeeze bottle filles with 50, 100 and 200 mL. Intensity of local staining and percentage of area were documented using standardized videoendoscopy after irrigation in 'bending over the sink' or 'vertex to floor' position. Grading was performed by two independent observers for 23 anatomic regions, including the stained circumference of maxillary and frontal ostia. To evalute the influence of the anatomy, acoustic rhinometry was performed. ANOVA was used to evaluate effects of application methods and head positions using GenStat 8.2 (Lawes Agricultural Trust, Rothamsted Experimental Station, Harpenden, UK) using an appropriate block structure. Results: With regard to the frontal sinus, we were able to show clear superiority of the squeeze bottle technique filled with 200mL and applied in the 'vertex to floor' position. Conclusion: In a relatively fit and flexible patient the 'vertex to floor' position using a squeeze bottle technique is advocated. There may be some patients, however, for whom this position is not feasible. In these patients 'bending over the sink', while inferior to the 'vertex to floor' position, still ensures some irrigation of the frontal sinus.</p>

	]]>
</description>

<author>A Beule et al.</author>


</item>






<item>
<title>Comprehensive surgical management of the aerosinusitis patient</title>
<link>http://works.bepress.com/peterj_wormald/17</link>
<guid isPermaLink="true">http://works.bepress.com/peterj_wormald/17</guid>
<pubDate>Thu, 01 Oct 2009 22:19:58 PDT</pubDate>
<description>
	<![CDATA[
	<p>Barotrauma can be defined as damage occurring to body structures resulting from ambient pressure change. As an individual's alititude increases from sea level, atmospheric pressure will decrease. If this change in pressure occurs more rapidly than the body's compensatory mechanisms can accommodate, discomfort or physcial damage will result. The middle ear spaces and paranasal sinuses are the structures most likely to be affected by barotrauma. The term 'aerosinusitis' has been applied to sinus difficulties resulting from barotrauma. The diagnosis of aerosinusitis requires simultaneous occurrence of a sinus cavity pressure differential and sinus related discomfort [1]. Frontal pain is the most common symptom in both military and civilian aerosinutis; however, civilian incidents rarely result in significant issues [2,3]. Military pilots are exposed to greater physiologic extremes and thus are at risk for worse barotrauma sequelae.</p>

	]]>
</description>

<author>E K. Weitzel et al.</author>


</item>





</channel>
</rss>

